Case Acceptance
A study found treatment intent rose 22% with a visualization. Here is what that figure actually measures, what it does not promise, and where a lift like it would show up in a cosmetic chair.
Simulated preview — a visualization aid, not a guaranteed outcome.
A 2023 study found that patients’ stated intention to accept treatment rose 22% when a visualization system replaced verbal explanation — a third-party finding that points to a lever, not a guaranteed number for your clinic. Understood honestly, it says something useful about cosmetic dentistry: the biggest barrier to a yes is often that the patient cannot picture the result. Here is what the figure measures, what it does not, and where a lift like it would show up in your practice.
The number comes from a study in Healthcare in which patients’ intention to accept treatment rose by 22% when a visualization system communicated the plan instead of the traditional verbal approach (Ye et al., 2023). Two details matter for using it honestly: it measured stated intent, not booked-and-paid revenue, and it was an orthodontic study. So it is best read as directional evidence that seeing the outcome moves the decision — a mechanism that carries across cosmetic dentistry — rather than a promise that any specific clinic will see exactly 22% more cases.
No — this is independent published research, not our own claim. We cite it because it describes the mechanism our tool is built around, not because it measures our tool. Smileproof does not claim to raise your case acceptance by a set percentage; anyone who promises a fixed uplift from a preview is overselling. The honest position is that visualization removes the single largest barrier to a cosmetic yes — not being able to picture the result — and that the direction is well supported. Keeping that distinction clear is part of the same candor that builds patient trust in the chair: a preview is a visualization aid, not a guarantee.
If seeing the result moves stated intent, the effect surfaces at specific, measurable points in your funnel rather than as one vague bump in production.
| Funnel point | What a visualization lever tends to move |
|---|---|
| Same-visit close rate | More patients decide on the day, while interest is highest |
| “I’ll think about it” rate | Fewer deferrals, because the picture answers the real uncertainty |
| Preview-to-consult conversion | More previewed patients book, especially from a widget or website |
| Time-to-decision | Shorter, because the patient is not waiting to imagine the result |
Watching these is how you would know whether a preview-first consult is working in your own clinic — the honest alternative to trusting a borrowed percentage. The metric set is in how clinic managers can track and lift acceptance.
The research direction only helps if the consult is built to use it. That means showing a preview of the patient’s own smile at every cosmetic consult, framing it honestly, presenting the plan in plain language, and asking for a decision with a specific next step. The tool is a lever, not a cure — a clinic that owns a simulator but keeps presenting price-first and skipping the reveal will not move its number. Put the picture at the center of the conversation and measure the funnel, and you replace a hopeful percentage with your own real one. That own number, unlike a borrowed one, tells you whether the change is worth keeping and where in the consult it is paying off — something a figure from a paper can never do for your clinic.
A number lifted from a study and quoted as your own expected result sets a trap: if your clinic does not hit it, the tool looks broken, and if it does, you have learned nothing about why. Published figures like the +22% describe a mechanism under specific conditions, not a guarantee for your case mix, fees, and patients. The responsible use is directional — “this tells us visualization matters” — not literal. That is also why we never print a claimed uplift on our own pages: a preview is a visualization aid, not a guarantee, and honesty about what the evidence does and does not say is part of the same trust that closes cases in the chair.
Your own. The figure that matters is your clinic’s case-acceptance trend on comparable cosmetic plans, measured before and after you change the consult. If you add a preview-first consult and your same-visit close rate and “think about it” rate both improve over the next quarter, you have real evidence — specific to your patients — that the lever works for you. A borrowed 22% is a reason to run the experiment; your own tracked funnel is the result. Judge the change against your own prior quarter, not against someone else’s published percentage.
The most useful way to hold the +22% figure is as a reason to change the consult, not as a target to quote to patients or staff. It tells you that visualization matters, strongly and consistently; it does not tell you your exact result, which only your own tracked funnel can. Used that way — as evidence of a lever, measured against your own prior quarter — it is one of the clearest arguments for a preview-first cosmetic consult. The full system sits in the case acceptance pillar. To see a preview-first consult on your own patients, book a demo — qualified clinics get a trial set up personally after a short demo.
Book a 20-minute demo and leave with a 30-day pilot — 100 previews and 5 lab reports, no card.
Book a demo →